Chris Surr, Mutant's head of sales and marketing, claims a lot of interest from banks, although no deal originating on the exchange has yet been closed.
They believe a single type of cell may be cancer's main growth engine:mutant stem cells that, though barely present, spawn other cells that then spark growth.
